Drugs Flashcards
methotrexate
DMARD 2.5 mg tab, max 10 tab.
sulfasalazine
DMARD azulfidine
0.5g-1g PO divided daily, max 4g daily
plaquenil
DMARD hydroxychloroquine
200mg tabs daily
max 400mg daily
arava
DMARD leflunomide
max 20 mg daily
imuran
DMARD azathioprine
1mg/kg daily (can divide BID)
max 2.5mg daily
enbrel
TNF Inhibitor
Etanercept
SQ weekly
Humira
TNF Inhibitor
Adalimumab
SQ every 2 weeks
can increase to weekly
Simponi
TNF Inhibitor
Golimumab
SQ monthly
Simponi Aria
TNF Inhibitor
Golumumab
- RA indication only
IV 2mg/kg at 0, 4, then every 8 weeks (first one, one month later, then every 2 months)
Cimzia
TNF Inhibitor
Certolizumab pegol
Remicade
TNF Inhibitor
Infliximab
IV 3mg/kg at 0,2,6 weeks then every 4-8 weeks,
max 10mg/kg every 4-8 weeks
Actemra
Tocilizumab IL - 6 antagonist IV 8mg/kg q4 weeks Start: IV 4mg/kg with max 800mg or SQ 162 mg weekly if weight <100kg start q 2 weeks.
kinaret
anakinra
IL 1 antagonist
SQ 100mg daily
Ritxan
Rituximab
B cell antagonist
IV 1000mg every 2 weeks in 2 doses, repeat every 16-24 weeks.
give with solumedrol and zyrtec to combat infusion rxn.
Zeljanz
tofacitinib
JAK antagonist
5mg BID PO or 11mg daily
Orencia
abatacept
decreases immature T cell activation
weight based dosing
-IV <60kg: 500mg on weeks 0, 2, 4; then every 4 weeks
-IV 60-100kg: 750mg on weeks 0, 2, 4; then every 4 weeks
-IV 100kg: 1000mg on weeks 0, 2, 4; then every 4 weeks
-SQ 125mg weekly after loading dose according to the above IV guidelines
Fosamax
alendronate
inhibits osteoclast bone resorption
70mg weekly PO
Actonel
Risedronate
inhibits osteoclast bone resorption
35mg weekly PO
Boniva
Ibandronate
Inhibits osteoclast bone resorption
150mg monthly PO
Evista
Raloxifene
SERM = estrogen agonist, prevents bone loss
60mg daily PO
Prolia
denosumab
Binds to RANKL to prevent osteoclast formation
SQ 60mg every 6 months